Long-term clinical outcomes after sirolimus-eluting stent implantation in dialysis patients

International Heart Journal

Volumn 51, Issue 2, 2010, Pages 92-97

  Ichimoto, Eiji ^a   Kobayashi, Yoshio ^a   Iijima, Yoshihiro ^b   Kuroda, Nakabumi ^a   Kohno, Yukinori ^b   Komuro, Issei ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Chiba Social Insurance Hospital   (Japan)

Author keywords

Angioplasty; Dialysis; Renal failure; Stent

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT THROMBOSIS; TREATMENT DURATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951465731     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.92     Document Type: Article

References (30)

1. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
3. Ishio N, Kobayashi Y, Takebayashi H, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007; 71: 1525-9.
4. Sasao H, Hotta D, Maeda T, Saito N, Takagi S, Shimamoto K. Comparison of long-term clinical outcome after sirolimus-eluting stent implantation in patients with and without hemodi-alysis. Int Heart J 2007; 48: 689-700.
5. Aoyama T, Ishii H, Toriyama T, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56-60.
6. Okada T, Hayashi Y, Toyofuku M, et al. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J 2008; 72: 1430-5.
7. Kitahara H, Kobayashi Y, Takebayashi H, et al. Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals. Circ J 2009; 73: 867-71.
8. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007; 369: 667-78.
9. Kadohira T, Kobayashi Y, Asano T, et al. Fatal very late stent thrombosis in a young diabetic patient with severely diffuse coronary atherosclerosis. Int Heart J 2008; 49: 507-13.
10. Colombo A, Orlic D, Stankovic G, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamy-cin-eluting stent implantation. Circulation 2003; 107: 2178-80.
11. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872-8.
12. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cut-lip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-9.
13. Marso SP, Gimple LW, Philbrick JT, DiMarco JP Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis. Am J Car-diol 1998; 82: 378-80.
14. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Gior-gi LV, Hartzler GO. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990; 119: 484-9.
15. Azar RR, Prpic R, Ho KK, et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000; 86: 485-9.
16. Das P, Moliterno DJ, Charnigo R, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 2006; 18:405-8.
17. Hassani SE, Chu WW, Wolfram RM, et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 2006; 18: 273-7.
18. Daemen J, Lemos P, Aoki J, et al. Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-year clinical follow-up of a consecutive series of cases. J Invasive Cardiol 2004; 16: 685-7.
19. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with he-modialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10: 354-65.
20. Mitamura Y, Murabayashi S. The Japanese artificial organs scene: current status. Artif Organs 2005; 29: 675-80. (Review)
21. Nose Y. Don't kill Japanese hemodialysis patients like America kills its patients. Artif Organs 1998; 22: 271-2.
22. Shinzato T, Nakai S, Akiba T, et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12: 884-8.
23. Renal Data System: USRDS 2000 Annual Data Report. Bethes-da, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2000.
24. Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004; 109: 2273-8.
25. Bocksch W, Fateh-Moghadam S, Mueller E, Huehns S, Waigand J, Dietz R. Percutaneous coronary intervention in patients with end-stage renal disease. Kidney Blood Press Res 2005;28:275-9. (Review)
26. Asano T, Kobayashi Y, Mintz GS, et al. Effect of plaque volume on subsequent vessel remodeling at edges of sirolimus-eluting stents. Am J Cardiol 2006; 98: 1041-4.
27. Fujii K, Mintz GS, Kobayashi Y, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004; 109: 1085-8.
28. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-88.
29. Kitahara H, Kobayashi Y, Yamaguchi M, et al. Damage to polymer of undelivered sirolimus-eluting stents. J Invasive Cardiol 2008; 20: 130-3.
30. Kitahara H, Kobayashi Y, Yamaguchi M, et al. Damage to polymer of paclitaxel-eluting stent. Circ J 2008; 72: 1907-8.